Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120

Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120

Bibliographic Details
Main Authors:	Zhou, T, Moquin, S, Lynch, R, Wu, X, Zhu, J, Yang, Y, Zhang, B, Mascola, JR, Kwong, PD
Format:	Online
Language:	English
Published:	BioMed Central 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442089/

Similar Items

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface
by: Huang, Jinghe, et al.
Published: (2014)

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies
by: Joyce, M, et al.
Published: (2012)

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site
by: Dai, K, et al.
Published: (2012)

Eliciting neutralizing antibodies with gp120 outer domain
by: Qin, Y, et al.
Published: (2012)

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8
by: Ofek, G, et al.
Published: (2012)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
by: Huang, Jinghe, et al.
Published: (2012)

Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization
by: Acharya, P, et al.
Published: (2012)

Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.
by: Rachel C Doran, et al.

Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding
by: Panico, Maria, et al.
Published: (2016)

A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1
by: Gach, Johannes S., et al.
Published: (2013)

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
by: Matz, J, et al.
Published: (2012)

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
by: McCoy, Laura E., et al.
Published: (2012)

Broad neutralization coverage of HIV by multiple highly potent antibodies
by: Walker, Laura M., et al.
Published: (2011)

Structural elements of primary CCR5-using HIV-1 gp120 proteins influencing sensitivity and resistance to the broadly neutralizing monoclonal antibody b12
by: Sterjovski, J., et al.
Published: (2012)

Correction: CD169-Mediated Trafficking of HIV to Plasma Membrane Invaginations in Dendritic Cells Attenuates Efficacy of Anti-gp120 Broadly Neutralizing Antibodies
Published: (2015)

CD169-Mediated Trafficking of HIV to Plasma Membrane Invaginations in Dendritic Cells Attenuates Efficacy of Anti-gp120 Broadly Neutralizing Antibodies
by: Akiyama, Hisashi, et al.
Published: (2015)

Characterizing the fitness cost of viral escape from the HIV-1 broadly neutralizing monoclonal antibody VRC01
by: Lynch, RM, et al.
Published: (2012)

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies
by: Doria-Rose, NA, et al.
Published: (2012)

NMR spectroscopy of HIV-1 gp120 outer domain
by: Sastry, M, et al.
Published: (2012)

Allosteric Modulation of the HIV-1 gp120-gp41 Association Site by Adjacent gp120 Variable Region 1 (V1) N-Glycans Linked to Neutralization Sensitivity
by: Drummer, H., et al.
Published: (2013)

Allosteric Modulation of the HIV-1 gp120-gp41 Association Site by Adjacent gp120 Variable Region 1 (V1) N-Glycans Linked to Neutralization Sensitivity
by: Drummer, Heidi E., et al.
Published: (2013)

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
by: Liao, Hua-Xin, et al.
Published: (2013)

Broadly Neutralizing Antibodies for HIV Eradication
by: Stephenson, Kathryn E., et al.
Published: (2016)

Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
by: Ma, Ben-Jiang, et al.
Published: (2011)

Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41
by: Zhang, Mei-Yun, et al.
Published: (2012)

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
by: Shingai, Masashi, et al.
Published: (2014)

Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation
Published: (1996)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1
by: Ruprecht, Claudia R., et al.
Published: (2011)

HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
by: Kovacs, JM, et al.
Published: (2012)

Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate
by: Narayan, Kristin M., et al.
Published: (2013)

Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120
by: West, AP, et al.
Published: (2012)

Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking
by: Chuang, G, et al.
Published: (2012)

Effects of Darwinian Selection and Mutability on Rate of Broadly Neutralizing Antibody Evolution during HIV-1 Infection
by: Sheng, Zizhang, et al.
Published: (2016)

Role of anti-CD4-binding site antibodies in modulating gp120-specific CD4 T cell and antibody responses
by: Visciano, ML, et al.
Published: (2006)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
by: Rusert, Peter, et al.
Published: (2011)

Isolation of broadly neutralizing HIV-1 antibodies from high-throughput single B cell culture
by: Longo, NS, et al.
Published: (2012)

HIV-1 gp41 Core with Exposed Membrane-Proximal External Region Inducing Broad HIV-1 Neutralizing Antibodies
by: Wang, Ji, et al.
Published: (2011)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han, D, et al.
Published: (2012)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
by: Verkoczy, Laurent, et al.
Published: (2014)

Retraction: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
by: Han, D, et al.
Published: (2014)